Eiger BioPharmaceuticals, Inc. Uncategorized Contracts & Agreements

29 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Promotion Letter Agreement, dated as of September 21, 2023, by and between Eiger BioPharmaceuticals, Inc. and Ingrid Choong
Eiger BioPharmaceuticals, Inc.
Biotechnology
2023
Offer Letter Agreement, dated as of
Eiger BioPharmaceuticals, Inc.
Biotechnology
CA
2023
Offer Letter Agreement, dated as of January 9, 2023, by and between Eiger BioPharmaceuticals, Inc. and David Apelian
Eiger BioPharmaceuticals, Inc.
Biotechnology
DE
2023
Open Market Sale AgreementSM, dated March 25, 2022, by and between Eiger BioPharmaceuticals, Inc. and Jefferies LLC
Eiger BioPharmaceuticals, Inc.
Biotechnology
NY
2022
Offer Letter Agreement, by and between Eiger BioPharmaceuticals, Inc. and Erik Atkisson, dated as of August 26, 2021
Eiger BioPharmaceuticals, Inc.
Biotechnology
CA
2021
2021 Inducement Plan
Eiger BioPharmaceuticals, Inc.
Biotechnology
2021
Open Market Sale AgreementSM, dated August 6, 2020, between Eiger BioPharmaceuticals, Inc. and Jefferies LLC
Eiger BioPharmaceuticals, Inc.
Biotechnology
NY
2020
Offer Letter Agreement, by and between the Registrant and Eldon Mayer, dated as of December 3, 2019
Eiger BioPharmaceuticals, Inc.
Biotechnology
CA
2020
Description of Registrants Securities
Eiger BioPharmaceuticals, Inc.
Biotechnology
2020
Amended and Restated Offer Letter Agreement, dated as of November 1, 2019, by and between Eiger Biopharmaceuticals, Inc. and James Shaffer
Eiger BioPharmaceuticals, Inc.
Biotechnology
CA
2019
Amended and Restated Offer Letter Agreement, dated as of November 1, 2019, by and between Eiger Biopharmaceuticals, Inc. and Stephana E. Patton
Eiger BioPharmaceuticals, Inc.
Biotechnology
CA
2019
Amended and Restated Offer Letter Agreement, dated as of November 1, 2019, by and between Eiger Biopharmaceuticals, Inc. and Sriram Ryali
Eiger BioPharmaceuticals, Inc.
Biotechnology
CA
2019
Amended and Restated Offer Letter Agreement, dated as of November 1, 2019, by and between Eiger Biopharmaceuticals, Inc. and David A. Cory
Eiger BioPharmaceuticals, Inc.
Biotechnology
CA
2019
Offer Letter, dated as of November 30, 2018, by and between Eiger BioPharmaceuticals, Inc. and Sriram Ryali
Eiger BioPharmaceuticals, Inc.
Biotechnology
2019
Offer Letter, dated as of February 26, 2019, by and between Eiger BioPharmaceuticals, Inc. and Stephana Patton
Eiger BioPharmaceuticals, Inc.
Biotechnology
2019
Offer Letter, dated as of December 12, 2017, by and between Eiger BioPharmaceuticals, Inc. and David Apelian, M.D., Ph.D
Eiger BioPharmaceuticals, Inc.
Biotechnology
2018
EXCLUSIVE AGREEMENT
Eiger BioPharmaceuticals, Inc.
Biotechnology
CA
2015
EXCLUSIVE AGREEMENT
Eiger BioPharmaceuticals, Inc.
Biotechnology
CA
2015
L E A S E
Eiger BioPharmaceuticals, Inc.
Biotechnology
2015
SUPPORT AGREEMENT
Eiger BioPharmaceuticals, Inc.
Biotechnology
DE
2015
SUPPORT AGREEMENT
Eiger BioPharmaceuticals, Inc.
Biotechnology
DE
2015
Material Transfer and Exclusivity Agreement
Eiger BioPharmaceuticals, Inc.
Biotechnology
2014
INDEMNITY AGREEMENT
Eiger BioPharmaceuticals, Inc.
Biotechnology
DE
2013
Additional abbreviations may also be used though not in the above list. For value received, hereby sell(s), assign(s) and transfer(s) unto
Eiger BioPharmaceuticals, Inc.
Biotechnology
2013
SUBLICENSEAGREEMENT
Eiger BioPharmaceuticals, Inc.
Biotechnology
CA
2013
FOR THE PARTYOF THE FIRST PART Frank L. Graham President & Chief Executive Officer AdVec Inc. Ancaster, Ontario CANADA FOR THE PARTY OF THESECOND PART CELLADON CORPORATION 2223...
Eiger BioPharmaceuticals, Inc.
Biotechnology
2013
EXCLUSIVELICENSE AGREEMENT
Eiger BioPharmaceuticals, Inc.
Biotechnology
CA
2013
LICENSEAGREEMENT BETWEEN CELLADONCORPORATION AND THE REGENTSOF THE UNIVERSITY OF CALIFORNIA FOR CASE NO. [...***...] CASE NO. [...***...] CASE NO.[...***...] CASE NO. [...***...]...
Eiger BioPharmaceuticals, Inc.
Biotechnology
CA
2013
INDEMNITY AGREEMENT
Eiger BioPharmaceuticals, Inc.
Biotechnology
DE
2013